Amryt Pharma agrees Lojuxta distribution deal for Romania and Bulgaria

By Andrew Scott / February 02, 2018 / www.proactiveinvestors.co.uk / Article Link

Dave Allmond, chief commercial officer at Amryt Pharma PLC (LON:AMYT), discusses with Proactive their fourth distribution deal signed in three months for Lojuxta.

Lojuxta treats a very rare, life-threatening genetic condition which causes "bad cholesterol" to accumulate in the body. 

This latest agreement, covering Romania and Bulgaria, is with Romastru Trading, part of the Pharaon Healthcare Europe conglomerate.

 Meet Anglo Asian Mining Plc, Condor Gold PLC, Connemara Mining and Papua Mining PLC at our event, London, 08 February 2018.Register here >>

Recent News

Gold stocks decline on flat metal and mixed equities

October 07, 2024 / www.canadianminingreport.com

Copper price expected to range from flat to slight gain in 2025

October 07, 2024 / www.canadianminingreport.com

China's gold holdings to central bank reserves still low

September 30, 2024 / www.canadianminingreport.com

China has broad effect on gold market

September 30, 2024 / www.canadianminingreport.com

Gold stocks mixed after previous week's huge gains

September 23, 2024 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok